• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Segments Analyzed Are Injectables, Solid Dosage Forms, and Liquid Dosage Forms for Pharmaceutical Contract Manufacturing 2000 - 2009

Posted on: Wednesday, 23 August 2006, 12:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c41044) has announced the addition of Pharmaceutical Contract Manufacturing - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in Millions of US$. Major product segments anaylzed are Injectables, Solid Dosage Forms, and Liquid Dosage Forms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 79 companies including many key and niche players worldwide.

Content Titles Include:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II.

1. Industry Overview

2. Trends & Issues

3. Service Overview

4. Recent Industry Activity

5. Focus on Select Global Players

6. Global Market Perspective

III. MARKET

Some Companies Mentioned in Report:

Abbott- Biologics & Pharmaceutical Contract

Manufacturing (USA)

Akorn, Inc (USA)

Althea Technologies (USA)

AMCAPHARM Pharmaceutical GmbH (Germany)

Apoteket AB Produktion & Laboratorier (APL) (Sweden)

Applied Laboratories, Inc (USA)

ATOZ Pharmaceuticals (India)

Baccinex SA (Switzerland)

BASF Pharma Solutions (Germany)

Baxter BioPharma Solutions (USA)

Beltapharm SpA (Italy)

Ben Venue Laboratories, Inc (USA)

BioInvent International AB (Sweden)

BioProgress PLC (UK)

BioZone Laboratories, Inc (USA)

Bluepharma (Portugal)

Brawn Laboratories Ltd (India)

Bushu Pharmaceuticals Ltd (Japan)

Cardinal Health, Inc (USA)

Celltech Manufacturing Services Ltd (UK)

Cenexi, Roche Group (France)

Ciron Drugs & Pharmaceuticals (P) Ltd (India)

Confab Laboratories, Inc (Canada)

Cook Pharmica LLC (USA)

Crucell NV (The Netherlands)

Custom Pharmaceuticals Ltd (UK)

Dalton Pharma Services (Canada)

Delpharm (France)

Dishman Pharmaceuticals and Chemicals Ltd (India)

Dragenopharm GmbH & Co KG (Germany)

Draxis Health, Inc (Canada)

DSM Biologics (USA)

Fine Foods NTM SpA (Italy)

Fuji Chemical Industry Co, Ltd (Japan)

Hasco-Lek SA (Poland)

Haupt Pharma Ag (Germany)

Hikal Ltd (India)

Hollister-Stier Laboratories LLC (USA)

Keata Pharma, Inc (Canada)

Kemwell Pvt Ltd (India)

Laboratoires Panpharma SA (France)

Lannett Company, Inc (USA)

Laureate Pharma, Inc (USA)

Lipa Pharmaceuticals (Australia)

Lomapharm (Germany)

Lyka Labs (India)

Lyne Laboratories (USA)

Mallinckrodt Pharmaceuticals (USA)

Matrix Laboratories Limited (India)

McGuff Pharmaceuticals, Inc (USA)

Medico Labs, Inc (USA)

Meridian Enterprises Pvt, Ltd (India)

MP-Technopharma Corporation (Japan)

NextPharma Technologies (UK)

P J Noyes Co, Inc (USA)

Patheon, Inc (Canada)

Penn Pharmaceutical Services Limited (UK)

Perrigo Company (USA)

PharmaFab (USA)

Pierrel SpA (Italy)

Radico Remedies (India)

Recipharm Contract Manufacturing (Sweden)

Reliable Biopharmaceutical Corporation (USA)

Sphere Healthcare Pty, Ltd (Australia)

Stason Pharmaceuticals, Inc (USA)

Temmler Pharma GmbH & Co, KG (Germany)

The Chao Center (USA)

Therapex (Canada)

Tropon GmbH (Germany)

United Biomedical, Inc (USA)

UPM Pharmaceuticals (USA)

For more information visit http://www.researchandmarkets.com/reports/c41044

Source: Business Wire

More News in this Category